Drug Development

Fighting Programmed Cell Death

Interview with Morgane Rousselot, SeaBeLife

Noncanonical Amino Acids Made by Enzymes

Aralez Bio, a San Francisco-based start-up, has engineered a platform of enzymes that creates 100 times more compound diversity using processes that are also 50 times greener than conventional methods.

Novo Nordisk and Neomorph to Develop Molecular Glue Drugs

US biotechnology company Neomorph signed a $1.46 billion licensing agreement with Novo Nordisk to discover, develop and commercialize molecular glue degraders.

Quotient Sciences Bolsters Sterile Fill/Finish Capacity

Quotient Sciences, a drug development and manufacturing accelerator, has invested significantly in expanding its sterile fill/finish capabilities at its Alnwick, UK facility. This expansion aims to meet the rising demand in the industry for comprehensive drug development programs by enhancing the capacity of the Annex 1-compliant facility.

Daiichi Sankyo and Merck & Co. Collaborate on Three DXd ADCs Worldwide

Daiichi Sankyo and Merck & Co. to co-develop and commercialize three of Daiichi Sankyo’s DXd antibody-drug conjugate (ADC) candidates worldwide except for Japan where Daiichi Sankyo retains exclusive rights. Merck to pay Daiichi Sankyo up to €20.8 billion for the collaboration.

Providing Solutions by Making the Most of Biomedical Data

Many life science companies generate large swathes of data.

PTC Therapeutics Gets Funding from Blackstone for Drug Development

US biopharma PTC Therapeutics has entered into a financing collaboration with private equity group Blackstone so that it can achieve its goal of delivering at least one therapy every two-to-three years.

AI Makes Drug Discovery Faster

Interview with Joachim Haupt and Florian Kaiser, PharmAI

Nanoparticle Engineering

The value in applying AI in Pharma is in making new and better drugs available faster than would be possible otherwise. By augmenting sparse-data AI with expert knowledge and applying it to the latest nanoparticle engineering techniques, opportunities are created to eliminate the risk associated with new techniques and give therapeutics a second chance to reach the patients who need them.

Integrated Drug Development Models

Interview with Giovanna Libralon, Senior Director Commercial Development Small Molecules at Lonza.

A Virtual Formulation Assistant

BASF has created ZoomLab, a virtual formulation prediction and optimization tool, to help address the challenges of drug product development.

Merck Opens Drug Development Center in Shanghai

Under the name M Lab, Germany’s Merck has opened a new collaborative drug development center in Pudong, Shanghai, China. The facility with lab space of around 10,000 m2 is the largest of the pharmaceutical, chemicals and life science group’s nine such centers worldwide and is located in the heart of Shanghai’s biomedical sciences and research community.

Building a Culture of Analytic Excellence

Nanoforming

In 2019, the pharmaceutical industry invested $182 billion in drug development, but only 48 drugs were approved for use.

Expert Webinar: Accelerating Drug Commercialization

New therapies to address unmet and emerging medical needs are being discovered at an explosive rate, building on rapid advances in molecular biology and genetics.

DCAT Week 2019

Boehringer Ingelheim Buys ViraTherapeutics

Innovative Anti-Infectives

Digital Transformation

A Wide Spectrum of Contract Services

Pharma: Adapting to an Ever-Changing Environment

East or West? East and West!

Industry 4.0 and the Pharmaceutical Industry

Bernard Pluta Appointed as President of Recipharm’s Development Services

Ergomed Buys Dutch-based PSR Group

ISPE Recognizes Leaders in Drug Shortage Prevention

Opportunities in Drug Development and Manufacturing

Growth in the global oncology drug market is an important measure of opportunities in drug development and manufacturing, including for contract manufacturers of active pharmaceutical ingredients (APIs) and finished drug products.

Recipharm Acquires Italy’s Mitim

Lonza Expands Drug Product Services

DCAT Week ’16

Route Planner for Research Chemists

Recipharm in Ophthalmic Collaboration with Alcon

Recipharm to Take Majority of Indian Firm

Heavy Reliance on Contract Manufacturing

Johnson Matthey Acquires Pharmorphix